BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19337254)

  • 21. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.
    Kumari S; Puneet ; Prasad SB; Yadav SS; Kumar M; Khanna A; Dixit VK; Nath G; Singh S; Narayan G
    Med Oncol; 2016 May; 33(5):40. PubMed ID: 27034264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Despite activation of EGF-receptor-ERK signaling pathway, epithelial proliferation is impaired in portal hypertensive gastric mucosa: relevance of MKP-1, c-fos, c-myc, and cyclin D1 expression.
    Kawanaka H; Tomikawa M; Baatar D; Jones MK; Pai R; Szabo IL; Sugimachi K; Sarfeh IJ; Tarnawski AS
    Life Sci; 2001 Nov; 69(25-26):3019-33. PubMed ID: 11758828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.
    Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX
    PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
    Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
    Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
    Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
    Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma.
    Naef M; Yokoyama M; Friess H; Büchler MW; Korc M
    Int J Cancer; 1996 May; 66(3):315-21. PubMed ID: 8621250
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Gunawardhana N; Jang S; Choi YH; Hong YA; Jeon YE; Kim A; Su H; Kim JH; Yoo YJ; Merrell DS; Kim J; Cha JH
    Front Cell Infect Microbiol; 2017; 7():541. PubMed ID: 29379775
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction and expression of cyclin D3 in human pancreatic cancer.
    Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
    Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
    J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells.
    Kida A; Kakihana K; Kotani S; Kurosu T; Miura O
    Oncogene; 2007 Oct; 26(46):6630-40. PubMed ID: 17486076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
    Nanba D; Mammoto A; Hashimoto K; Higashiyama S
    J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
    Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
    Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
    Liu YL; Jiang SX; Yang YM; Xu H; Liu JL; Wang XS
    Cell Biochem Biophys; 2012 Jan; 62(1):229-35. PubMed ID: 21928107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK; Lee JJ; Yang Y; You KH; Lee JH
    Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of REIC gene and its encoding product in gastric carcinoma.
    Xu XY; Xia P; Yu M; Nie XC; Yang X; Xing YN; Liu YP; Takano Y; Zheng HC
    Cell Cycle; 2012 Apr; 11(7):1414-31. PubMed ID: 22421143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Madapura HS; Nagy N; Ujvari D; Kallas T; Kröhnke MCL; Amu S; Björkholm M; Stenke L; Mandal PK; McMurray JS; Keszei M; Westerberg LS; Cheng H; Xue F; Klein G; Klein E; Salamon D
    Oncogene; 2017 Aug; 36(32):4619-4628. PubMed ID: 28368400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
    Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
    Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-kB)-Dependent Pathway.
    Cheng Y; Che X; Zhang S; Guo T; He X; Liu Y; Qu X
    Med Sci Monit; 2020 Sep; 26():e925019. PubMed ID: 32881844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.